The invention relates to antibodies which bind to the CD23 (FCRII) type II molecule particularly altered antibodies including antibodies which bind to the CD23 (FCRII) type II molecule characterized by an affinity constant equal to or greater than 1109 Ka Mol-1, the preparation of such antibodies, pharmaceutical compositions which contain such antibodies and their use in therapy particularly in the treatment of autoimmune and inflammatory disorders.

 
Web www.patentalert.com

< System for cell-based screening

< Method and apparatus for tracking carcasses

> Biometric measuring system with detachable announcement device

> Surface plasmon resonance sensor having real-time referencing

~ 00244